Residual immunological risks associated with red blood cell transfusion.
Rouger
P
P
Centre National de Référence pour les Groupes Sanguins, Université Pierre et Marie Curie, Paris, France.
Le Pennec
P Y
PY
D016913:Blood Component Transfusion / Q000009:adverse effects*; D001787:Blood Group Incompatibility / Q000209:etiology*; D006086:Graft vs Host Disease / Q000209:etiology*; D006801:Humans; D009369:Neoplasms / Q000209:etiology; D012306:Risk